Gluvi’s Founder Presents Research at ATTD 2025

Gluvi’s founder participated in the Advanced Technologies & Treatments for Diabetes (ATTD) Conference 2025, one of the leading international events focused on innovation in diabetes technology and care.

During the conference, Gluvi’s founder delivered a Short Oral Presentation presenting a research project on the use of advanced artificial intelligence models for predicting blood glucose levels and the challenges associated with their integration into clinical and patient-facing contexts.

The work was published in Diabetes Technology & Therapeutics, Vol. 27 (Supplement 2), in conjunction with the ATTD conference proceedings.

🔗 Publication
Bada, O. (2025). Advanced AI models for predicting blood glucose levels in patients with diabetes: capabilities, limitations, and challenges of clinical integration.
Diabetes Technology & Therapeutics, Vol. 27 (Suppl. 2).

This research reflects the scientific foundations behind Gluvi and informs the product’s long-term vision of building responsible, evidence-informed digital tools for people living with diabetes.